AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 137.1 SEK 0.22% Market Closed
Market Cap: 16.7B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AddLife AB
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Free Cash Flow
kr465m
CAGR 3-Years
-18%
CAGR 5-Years
29%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Free Cash Flow
-kr112.8m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Free Cash Flow
kr243m
CAGR 3-Years
-4%
CAGR 5-Years
11%
CAGR 10-Years
20%
G
Genovis AB
STO:GENO
Free Cash Flow
kr37.3m
CAGR 3-Years
73%
CAGR 5-Years
60%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Free Cash Flow
kr250.5m
CAGR 3-Years
48%
CAGR 5-Years
26%
CAGR 10-Years
31%
M
Magle Chemoswed Holding AB
STO:MAGLE
Free Cash Flow
kr209k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

AddLife AB
Glance View

Market Cap
16.7B SEK
Industry
Life Sciences Tools & Services

AddLife AB, a prominent player in the life sciences sector, intricately weaves its narrative through a commitment to enhancing healthcare and laboratory services across Europe. Founded in Sweden, the company has established itself as a crucial intermediary, effectively bridging the gap between manufacturers of medical devices and the healthcare institutions that require them. AddLife operates by acquiring and developing niche companies within two core segments: Labtech and Medtech. Through Labtech, it supplies essential equipment, instruments, and consumables for diagnostic and research laboratories. In Medtech, it provides a variety of healthcare logistics, medical products, and services to hospitals and care facilities, enhancing their operational efficiencies. The financial heartbeat of AddLife rests on its adeptness at creating value through strategic acquisitions and organic growth, capitalizing on the increasing demand for innovative healthcare solutions. By continuously expanding its product portfolio and enhancing the capabilities of its subsidiaries, AddLife ensures a diversified revenue stream, mitigating risks associated with dependence on any single product or market. This approach not only fortifies their market position but also fuels their profit margins, as they deftly respond to shifting industry demands and regulatory changes. The company's shared values and decentralized business model promote entrepreneurship within its subsidiaries, fostering an environment where innovation can thrive—ensuring their continued success and substantial contribution to the evolving landscape of healthcare.

ALIF B Intrinsic Value
158.23 SEK
Undervaluation 13%
Intrinsic Value
Price

See Also

What is AddLife AB's Free Cash Flow?
Free Cash Flow
465m SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Free Cash Flow amounts to 465m SEK.

What is AddLife AB's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
29%

Over the last year, the Free Cash Flow growth was -26%. The average annual Free Cash Flow growth rates for AddLife AB have been -18% over the past three years , 29% over the past five years .

Back to Top